Pfizer and BioNTech receive U.S. FDA approval for Omicron KP.2-adapted COVID-19 vaccine
The approval is based on the full body of previous clinical, non-clinical, and real-world evidence supporting the safety and effectiveness of the COVID-19 vaccines by Pfizer and BioNTech.